116 related articles for article (PubMed ID: 32248342)
21. Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos.
Gutzman JH; Nikolai SE; Rugowski DE; Watters JJ; Schuler LA
Mol Endocrinol; 2005 Jul; 19(7):1765-78. PubMed ID: 15746191
[TBL] [Abstract][Full Text] [Related]
22. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.
Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z
Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932
[TBL] [Abstract][Full Text] [Related]
23. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
Milde-Langosch K; Röder H; Andritzky B; Aslan B; Hemminger G; Brinkmann A; Bamberger CM; Löning T; Bamberger AM
Breast Cancer Res Treat; 2004 Jul; 86(2):139-52. PubMed ID: 15319566
[TBL] [Abstract][Full Text] [Related]
24. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
[TBL] [Abstract][Full Text] [Related]
25. Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.
Milke L; Schulz K; Weigert A; Sha W; Schmid T; Brüne B
Carcinogenesis; 2013 Apr; 34(4):850-7. PubMed ID: 23241166
[TBL] [Abstract][Full Text] [Related]
26. Identification of a GABP alpha/beta binding site involved in the induction of oxytocin receptor gene expression in human breast cells, potentiation by c-Fos/c-Jun.
Hoare S; Copland JA; Wood TG; Jeng YJ; Izban MG; Soloff MS
Endocrinology; 1999 May; 140(5):2268-79. PubMed ID: 10218980
[TBL] [Abstract][Full Text] [Related]
27. Tristetraprolin-RNA interaction map reveals a novel TTP-RelB regulatory network for innate immunity gene expression.
Tu Y; Wu X; Yu F; Dang J; Wei Y; Yu H; Liao W; Zhang Y; Wang J
Mol Immunol; 2020 May; 121():59-71. PubMed ID: 32163759
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of the glucocorticoid-induced leucine zipper (GILZ) promotes vascular inflammation.
Hahn RT; Hoppstädter J; Hirschfelder K; Hachenthal N; Diesel B; Kessler SM; Huwer H; Kiemer AK
Atherosclerosis; 2014 Jun; 234(2):391-400. PubMed ID: 24747114
[TBL] [Abstract][Full Text] [Related]
29. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
[TBL] [Abstract][Full Text] [Related]
30. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A; Shealy YF; Hill DL; Zhang X
Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
[TBL] [Abstract][Full Text] [Related]
31. Tristetraprolin regulates necroptosis during tonic Toll-like receptor 4 (TLR4) signaling in murine macrophages.
Ariana A; Alturki NA; Hajjar S; Stumpo DJ; Tiedje C; Alnemri ES; Gaestel M; Blackshear PJ; Sad S
J Biol Chem; 2020 Apr; 295(14):4661-4672. PubMed ID: 32094226
[TBL] [Abstract][Full Text] [Related]
32. EGF stimulates Pit-1 independent transcription of the human prolactin pituitary promoter in human breast cancer SK-BR-3 cells through its proximal AP-1 response element.
Manfroid I; Van de Weerdt C; Baudhuin A; Martial JA; Muller M
Mol Cell Endocrinol; 2005 Jan; 229(1-2):127-39. PubMed ID: 15607537
[TBL] [Abstract][Full Text] [Related]
33. Blockade of AP1 transactivation abrogates the abnormal expression of breast cancer-specific gene 1 in breast cancer cells.
Lu A; Zhang F; Gupta A; Liu J
J Biol Chem; 2002 Aug; 277(35):31364-72. PubMed ID: 12072430
[TBL] [Abstract][Full Text] [Related]
34. Tristetraprolin targets Nos2 expression in the colonic epithelium.
Eshelman MA; Matthews SM; Schleicher EM; Fleeman RM; Kawasawa YI; Stumpo DJ; Blackshear PJ; Koltun WA; Ishmael FT; Yochum GS
Sci Rep; 2019 Oct; 9(1):14413. PubMed ID: 31595002
[TBL] [Abstract][Full Text] [Related]
35. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
36. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
[TBL] [Abstract][Full Text] [Related]
37. FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas.
Milde-Langosch K; Kappes H; Riethdorf S; Löning T; Bamberger AM
Breast Cancer Res Treat; 2003 Feb; 77(3):265-75. PubMed ID: 12602926
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol epigenetically regulates the expression of zinc finger protein 36 in non‑small cell lung cancer cell lines.
Fudhaili A; Yoon NA; Kang S; Ryu J; Jeong JY; Lee DH; Kang SS
Oncol Rep; 2019 Feb; 41(2):1377-1386. PubMed ID: 30535453
[TBL] [Abstract][Full Text] [Related]
39. EGF-induced programmed cell death of human mammary carcinoma MDA-MB-468 cells is preceded by activation AP-1.
Schaerli P; Jaggi R
Cell Mol Life Sci; 1998 Feb; 54(2):129-38. PubMed ID: 9539953
[TBL] [Abstract][Full Text] [Related]
40. Jun and Fos family protein expression in human breast cancer: correlation of protein expression and clinicopathological parameters.
Langer S; Singer CF; Hudelist G; Dampier B; Kaserer K; Vinatzer U; Pehamberger H; Zielinski C; Kubista E; Schreibner M
Eur J Gynaecol Oncol; 2006; 27(4):345-52. PubMed ID: 17009623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
